Accelerate Pharma 4.0™ Knowledge with Exclusive On-Demand Learning Through ISPE Membership

Pharma 4.0™ is transforming every aspect of pharmaceutical manufacturing. Organizations are leveraging data-driven decision-making, digital twins, AI and machine learning, advanced automation, smart facilities, and connected supply chains to improve quality, efficiency, agility, and patient outcomes. At the same time, leaders must address workforce readiness, validation requirements, data governance, cybersecurity, and the cultural changes necessary to support long-term success.

To help professionals stay ahead, ISPE is offering new and renewing members access to a curated collection of expert-led, on-demand conference sessions through the Pharma 4.0™ learning pathway. Available by signing up for or renewing ISPE membership, these sessions feature practical implementation strategies, real-world case studies, emerging guidance, and lessons learned from organizations actively advancing digital transformation across the life sciences industry.

Whether responsibilities include manufacturing, quality, engineering, automation, validation, supply chain, digital transformation, or executive leadership, this learning pathway provides valuable insights into how Pharma 4.0™ is reshaping the future of pharmaceutical operations.

Expert-Led Pharma 4.0™ Sessions Available with ISPE Membership Registration or Renewal

• Tangible Digital Transformation Beyond Buzzwords: Many organizations launch digital transformation initiatives but struggle to move beyond pilots and achieve enterprise-wide impact. This panel discussion explores the hidden barriers that often derail transformation efforts, including fragmented data ownership, weak governance, resistance to change, and AI hype without clear business context.

Moderated by Christian Wölbeling, Executive Industry Advisor, Körber Pharma Software GmbH, the session features Michelangelo Canzoneri, PhD, Global Head of Group Smart Manufacturing, Merck KGaA, and Alexander Kunz, Quality Strategy Lead, Computerized Systems, Merck Healthcare KGaA. The discussion draws on principles from the ISPE Baseline Guide: Pharma 4.0™ (First Edition), which Canzoneri helped co-lead, and examines how organizations can transform ambition into measurable business value.

• Transforming Pharma 4.0™: ISPE's New Pharma 4.0 Guides: Discover two important new resources developed by the ISPE Pharma 4.0™ Community of Practice.

This session introduces the ISPE Good Practice Guide: Validation 4.0, which presents a modern, continuous, data-driven validation approach integrating quality by design, quality risk management, and digital technologies. It also explores the ISPE Good Practice Guide: Holistic Digital Enablement, offering practical strategies for leveraging AI, machine learning, Internet of Things, knowledge management, and data governance to improve decision-making, agility, and patient outcomes.

• Digital Transformation and GAMP^®: Practical Implementation: Successfully implementing digital innovation requires more than technology. Paige Kane, PhD, Associate Vice President, Technical Excellence and Transformation, CAI, and Brandi Stockton, Founder and Managing Partner, The Triality Group, LLC, share practical lessons learned from organizations navigating digital transformation within regulated environments.

Kane contributed to the ISPE Baseline Guide: Pharma 4.0™ (First Edition) and multiple GAMP publications, while Stockton serves on the GAMP Global Steering Committee and is the Guide Lead for the ISPE GAMP^® Guide: Artificial Intelligence. The session examines organizational change management, validation considerations for AI/machine learning systems, evolving regulatory expectations, and the role of quality assurance in supporting compliant innovation.

• New Facilities: Applying MES/Pharma 4.0™ Baseline Guides: Through a real-world case study, Paul Irving, Managing Director, Northern Life Sciences Ltd., and Robert Chabros, Project Manager, Northern Life Sciences Ltd., demonstrate how ISPE guidance can be applied to implement and validate an interconnected manufacturing facility, from initial risk assessment through commissioning.
   
• Digital Innovation to Enable Operational Excellence: Presented by Roberto Faucitano, PE, Senior Vice President and Site Head, Parenteral Drug Product and Device Manufacturing, Eli Lilly and Company, this session demonstrates how digital technologies are driving operational excellence in a major pharmaceutical manufacturing environment. Learn how virtual reality supports aseptic training, how AI improves defect detection and inspection processes, and how data-driven approaches such as release-by-exception can reduce variability, improve compliance, and accelerate decision-making.
   
• Workforce of the Future: Harnessing Workforce Skills to Embrace Pharma 4.0: In this Women in Pharma® supported presentation, Kate Marshall, Technical Director, Protak Scientific Ltd., explores how workforce generations, skills, and adaptability must evolve together to support Pharma 4.0 implementation. Through interactive audience participation and practical examples, the session highlights how organizations can strengthen core capabilities, navigate innovation challenges, and build teams prepared for continued transformation.
   
• Pharma 4.0™ 8th Edition Survey Deep Dive: Gain valuable benchmarking insights from the latest Pharma 4.0™ survey results. Teresa Minero, Strategic Advisor, LifeBee | a ProductLifeGroup Company, and Laura Kuger, Process Engineer, MS&T Drug Substance, Takeda, provide extended analysis of industry maturity levels, enabling technology adoption, cybersecurity concerns, implementation challenges, and emerging trends shaping digital transformation throughout the life sciences sector.
   
• Bridging Innovation and Compliance: Covering Annex 1 Requirements and Pharma 4.0 Technologies in a Fast Track Project Approach: Using Takeda's innovative beePFS project as a case study, Florian Keferböck, Lead, Manufacturing Science, Takeda, explores the intersection of Annex 1 requirements and Pharma 4.0 principles. Learn how Takeda incorporated advanced technologies, accelerated implementation timelines, and maintained compliance while building new manufacturing capabilities.
   
• Delivering Pharma 4.0 Through Model-Based Development: Model-based development, digital twins, and AI-enhanced processes are becoming standard tools across pharmaceutical development and manufacturing. Matt Popkin, PhD, Senior Director, CMC Excellence, GSK, shares insights from industry interactions with global regulators and explores the growing role of modeling, simulation, and AI/ML technologies in delivering Pharma 4.0 success.
   
• Digitalization and Sustainability: Path to Net-Zero: Sustainability and digital transformation are increasingly interconnected. In this session, Rodrigo Alves, Manager, Sustainability & Energy Management, Rockwell Automation, demonstrates how digital technologies and connected data systems help organizations optimize energy usage, reduce waste, improve efficiency, and support net-zero initiatives.
   
• Transforming Pharma Manufacturing: Sanofi's Journey Towards Digital Excellence in the Pharma 4.0 Era: Brendan O'Callaghan, Executive Vice President of Manufacturing and Supply, Sanofi, shares how Sanofi is implementing a digital-first, data-driven, AI-enabled manufacturing strategy. Learn how initiatives focused on standardization, simplification, digitization, analytics, and smart factories are helping create a more resilient and efficient supply chain.
   
• Designing for Pharma 4.0 – The Practical Considerations: Creating a successful digital facility starts long before commissioning. Mags Dalton, Group Head of Smart Manufacturing, PM Group, and Philip Ceary, Global Engineering Projects Technical Manager, AstraZeneca, discuss how Pharma 4.0 requirements can be incorporated during facility design to support smart manufacturing, data transparency, predictive maintenance, digital twins, and long-term operational success.
   
• Reinventing Machines: Shaping the Backbone of Pharma 4.0: Advanced equipment plays a critical role in digital transformation. Philipp Bayer, Product Owner, Rommelag iLabs GmbH, explores how machine connectivity, digital twins, secure architecture, and data standards are creating the foundation for smart factories and integrated manufacturing ecosystems.
   
• Modular Plants: A New ISPE Pharma 4.0 Good Practice Guide: Learn about the future of modular manufacturing from Rod Hoffman, IT/OT Connected Factory Business Partner, AstraZeneca, and Giuseppe Menin, Director, Life Sciences & Process Industry, COPA-DATA GmbH. This session introduces new work from ISPE's Plug & Produce initiative and explores how modular plant designs can deliver flexibility, scalability, and improved digital integration.
   
• Skilling Those Who Accelerate Pharma 4.0™ Transformations: Workforce development remains one of the industry's greatest challenges and opportunities. Malcolm Jeffers, Transformation Strategist and Head of Research, IAAE, and Martin Kockx, PE, Principal Engineer, Vertex, explore the critical skills, cultural enablers, and learning pathways required to support Pharma 4.0 transformation at scale.

Building the Future of Pharmaceutical Manufacturing

Collectively, these sessions demonstrate how Pharma 4.0™ continues to evolve from vision to reality. From digital strategy and smart manufacturing to AI governance, workforce development, validation, sustainability, and operational excellence, the learning pathway highlights both the opportunities and responsibilities that accompany digital transformation.

Participants gain exposure to proven implementation strategies, emerging guidance, real-world case studies, and practical approaches for scaling innovation while maintaining quality and compliance. Equally important, the content emphasizes the foundational elements necessary for success, including leadership, culture, interoperability, workforce readiness, and data governance.

For professionals seeking to strengthen digital capabilities, support organizational transformation, and prepare for the future of pharmaceutical manufacturing, this on-demand content offers a valuable opportunity to learn directly from industry leaders driving Pharma 4.0™ adoption across the life sciences sector.

Use promo code ISPE26PHARMA to secure access to the recordings when joining or renewing an ISPE membership.

Offer expires Friday, 25 September 2026.

Learn about the three learning pathways available to choose from.

Join or renew today.